UCB

Pharma

J&J data set up Imaavy for expansion to treat anemic disorder

J&J has unveiled data from a trial which could pave the way for a label expansion for Imaavy to become the first therapy for a rare autoimmune disease

Kevin Dunleavy Jun 11, 2026 10:36am

AbbVie, GSK race up patient reputation leaderboard in the UK

May 22, 2026 9:16am

UCB shares results for Bimzelx's PsA triumph over Skyrizi

May 19, 2026 11:27am

Summit, UCB-Candid, J&J—Fierce Pharma Asia

May 8, 2026 8:30am

UCB partners on meal program for MG patients

Apr 21, 2026 6:26am

UCB unveils plan to build $2B biologics plant in Georgia

Mar 24, 2026 2:56pm